LATEST NEWS
December 21, 2018 | Company Announcements
Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox VaccineNovember 13, 2018 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back ProgramNovember 09, 2018 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2018